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Angiography and Intervention suggest that a min‑
imum of 50 coronary interventional procedures 
have to be performed annually (over the averaged 
period of 2 years) to maintain competence (level 
of evidence C).3 In the United Kingdom, the Brit‑
ish Cardiovascular Interventional Society sup‑
ports the opinion that an independent operator 
INTRODUCTION Previous research has indicat‑
ed that low operator and institutional volume may 
be connected to a higher risk of adverse events in 
the setting of percutaneous coronary interven‑
tion (PCI).1,2 The current guidelines of the Amer‑
ican College of Cardiology, American Heart As‑
sociation, and the Society for Cardiovascular 
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ABSTRACT
BACKGROUND Previous studies have suggested that low operator and institutional volume may be 
associated with an increased risk of adverse events in patients undergoing percutaneous coronary 
intervention (PCI).
AIMS The aim of the study was to assess the relationship between operator volume and procedure­
­related mortality in the emergent and elective settings.
METHODS Data were obtained from a national registry of PCIs, maintained in cooperation with 
the Association of Cardiovascular Interventions of the Polish Cardiac Society. Registry data for the period 
from January 2014 to December 2017 were collected. During the study, there were 162 active catheterization 
laboratories, in which a total of 456 732 PCIs were performed.
RESULTS The median number of PCIs performed in a single laboratory was 2643.5 (interquartile range 
[IQR], 1875–3598.5) over 4 years. The median number of PCIs performed by a single operator was 557 (IQR, 
276.25–860.5) per year. We did not confirm a significant relationship between the operator volume and 
mortality in the overall group of patients treated with emergency and elective PCI. However, we noted 
a lower mortality rate for high ­volume operators (odds ratio [OR], 0.79; 95% CI, 0.63–0.99; P = 0.04). 
When the operator volume was assessed as a continuous variable, there was a trend toward significance 
(OR, 0.94; 95% CI; 0.88–1.0007; P = 0.052) in patients treated with emergency PCI.
CONCLUSIONS High operator volume was associated with a lower periprocedural mortality rate than 
low operator volume in patients undergoing PCI due to acute coronary syndromes.
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model. The model was adjusted for patient de‑
mographic data, medical history, and procedur‑
al details (ie, age, sex, weight, diabetes, previous 
stroke, previous PCI, previous coronary artery by‑
pass grafting, smoking, hypertension, kidney dis‑
ease, year of procedure, total site volume, use of 
fractional flow reserve, use of intravascular ultra‑
sound, use of optical coherence tomography, pre‑
procedural Thrombolysis In Myocardial Infarction 
[TIMI], indication for a procedure, chronic total 
occlusion, bifurcation, access site, as well as radi‑
ation and contrast dose). To analyze nonlinear re‑
lationships with an annualized operator volume 
and risk ‑adjusted mortality rate per operator, we 
used local polynomial regression. Operator vol‑
ume was assessed using quartiles and continu‑
ous variables with an intercept of 100 procedures. 
A P value of less than 0.05 was considered signif‑
icant. Statistical analyses were performed using 
the R software version 3.5.3 and the ‘lme4’ ver‑
sion 1.1–21 and ‘tidyverse’ version 1.2.1 packages 
(RStudio, Boston, Massachusetts, United States).
RESULTS The current analysis included all PCI 
procedures performed in Poland between Janu‑
ary 2014 and December 2017, which were avail‑
able in the ORPKI database, covering more than 
95% of all catheterization laboratories in Poland. 
During the study, there were 162 active lab‑
oratories, in which a total of 456 732 PCI pro‑
cedures were performed. The mean (SD) num‑
ber of PCIs in a single laboratory was 2819.3 
(1571.4) over 4 years, and the median num‑
ber was 2643.5 (IQR, 1875–3598.5). The low‑
est number of PCIs per laboratory over 4 years 
was 23 and the highest was 10 663. The overall 
number of operators during the study was 744, 
which gives 4.59 operators per one laboratory. 
The mean (SD) number of PCIs performed by one 
operator was 613.88 (459.24) over 4 years, which 
translates to a mean (SD) of 153.4 (114.8) PCIs 
per one operator annually. After exclusion of 
26 operators who performed fewer than 2 PCIs 
annually on average (8 PCIs/4 years), the mean 
(SD) number of PCIs performed by one opera‑
tor was 636 (452.2) over 4 years and 159 (113.8) 
PCIs annually. Of the 744 operators, 542 (72.8%) 
performed more than 75 PCIs annually and 596 
(80.1%) performed more than 50 PCIs annually. 
Considering the number of PCI procedures 
performed by individual operators during 
the 4 years, the first quartile (Q1, 0–140 pro‑
cedures/year) included 379 operators, the sec‑
ond (Q2, 141–212 procedures/year), 173 opera‑
tors; the third (Q3, 213–305 procedures/year), 
126 operators; and the fourth (Q4, ≥306 pro‑
cedures/year), 66 operators. Female operators 
performed 2.83% of all PCI procedures and had 
the largest share in Q1 and Q2, and the smallest, 
in Q3 and Q4 (4.08%, 5.23%, 0.83%, and 1.23% 
respectively, P <0.001).
should perform a  total of 150 procedures over 
a 2‑year period to sustain proficiency.4 Similar 
recommendations (class IIa; level of evidence C) 
are provided in the European Society of Cardi‑
ology guidelines concerning operators perform‑
ing PCIs for acute coronary syndromes (ACSs).5 
However, the available data on this relationship 
are contradictory. Some studies reported a higher 
operator volume to be associated with improved 
outcomes such as a reduction in the number of 
in ‑hospital deaths or other adverse events, but no 
such link was revealed by other investigators.6-15
The aim of this study was to assess the re‑
lationship between the operator volume and 
procedure ‑related mortality rate for elective 
and emergency PCI.
METHODS Materials Data for the current 
study were obtained from a national registry of 
PCIs (Ogólnopolski Rejestr Procedur Kardiologii 
Inwazyjnej [ORPKI]), maintained in cooperation 
with the Association of Cardiovascular Interven‑
tions of the Polish Cardiac Society. The registry is 
free of charge and covers almost all catheterization 
laboratories performing PCIs in Poland. Detailed 
characteristics of the registry were published pre‑
viously.16 Registry data for the period from Janu‑
ary 2014 to December 2017 were collected.
Statistical analysis  Continuous  variables were 
presented as mean (SD) and median (interquar‑
tile range [IQR]), depending on the normality 
of distribution assessed with the Kolmogorov– 
–Smirnov test. Categorical variables were pre‑
sented as numbers (percentages). Continuous 
variables were compared using the 2‑tailed t test 
and the Mann–Whitney test, while categorical 
variables, using the χ2 test or Fisher exact test 
when appropriate. To investigate the association 
between operator volume (defined as the total 
number of procedures the operator was respon‑
sible for in the previous 12 months) and peripro‑
cedural mortality in the presence of confound‑
ing and clustering effects (PCI operator), we used 
a multivariable mixed ‑effects logistic regression 
WHAT’S NEW?
Low operator and institutional volume may be associated with a higher risk 
of adverse events in the setting of percutaneous coronary intervention (PCI). 
In many countries, the ratio of PCI has changed from predominantly elective 
to an increased proportion of emergency procedures for acute coronary 
syndromes. In addition, interventional devices=, technologies, and pharmacology 
have improved; therefore, existing literature regarding the association between 
PCI volume and outcome may no longer apply to current practice. Therefore, we 
aimed to assess the relationship between the operator volume and procedure­
­related mortality in recent years. We demonstrated that operator volume is not 
associated with periprocedural mortality in the overall group of patients 
undergoing elective and emergency PCI. Primary interventions for acute coronary 
syndromes by high ­volume operators were related to a lower mortality rate.
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of bifurcated lesions, or rotational ablations, 
were significantly more often performed by high‑
‑volume operators. Other procedure‑related pa‑
rameters are presented in TABLE 2.
Procedure ‑related complications In the cur‑
rent study, the overall mortality rate was 0.46%, 
while the rate of no ‑reflow was 0.51%; cardi‑
ac arrest, 0.41%; coronary artery perforations, 
0.17%; allergic reactions, 0.14%; and bleeding 
at puncture site, 0.09%. No ‑reflow phenome‑
non occurred significantly more often in pa‑
tients treated by low ‑volume operators (Q1 and 
Q2). A similar negative correlation was observed 
between the operator volume and cardiac ar‑
rest (P <0.001), allergic reactions (P <0.01), and 
puncture ‑site bleeding (P <0.001).
Predictors of mortality in the overall group 
of patients In the overall group of patients 
treated with PCI, the multivariable analysis 
demonstrated no significant correlations be‑
tween the operator volume and procedure‑
‑related mortality, regardless of the method 
Baseline clinical characteristics Operators 
with a lower annual number of PCIs (Q1 and Q2), 
treated significantly younger patients in compar‑
ison with operators with a higher number of PCIs 
(Q3 and Q4). In general, potentially more difficult 
procedures, reflected by a higher number of pa‑
tients after previous PCI, coronary artery bypass 
grafting, and prior myocardial infarction, were 
performed by high ‑volume operators (Q3 and Q4). 
Moreover, high ‑volume operators treated patients 
with stable and unstable angina significantly more 
often, while low ‑volume operators generally more 
frequently treated patients with acute myocardi‑
al infarction and ACS. Similarly, patients with co‑
morbidities such as diabetes and kidney failure as 
well as a smoking habit were more often treated 
by low ‑volume operators (TABLE 1).
Procedure ‑related parameters Both a gen‑
eral and detailed assessment of vascular ac‑
cess revealed that high ‑volume operators used 
radial arteries significantly more often than 
 low ‑volume ones. More advanced procedures 
such as PCI of chronic total occlusions, PCI 
TABLE 1 Relationships between the number of percutaneous coronary interventions according to quartile 
and selected parameters during the 4‑year follow ‑up (2014–2017)
Parameter Total 
(n = 456 732)
Q1: 0–140 
(n = 113 587)
Q2: 141–212 
(n = 113 396)
Q3: 213–305 
(n = 113 295)
Q4: ≥306 
(n = 116 454)
P value
Age, y, mean (SD) 67.08 (10.7) 66.86 (10.8) 66.97 (10.8) 67.25 (10.8) 67.25 (10.6) <0.001
Male sex 30 8425 (67.9) 75 646 (67.9) 76 851 (67.8) 76 729 (67.7) 79 199 (68) 0.45
Diabetes 110 010 (24.1) 27 233 (24) 27 966 (24.7) 27 068 (23.9) 27 743 (23.8) <0.001
Prior cerebral 
stroke
14 940 (3.27) 3646 (3.21) 3592 (3.17) 3889 (3.43) 3813 (3.27) 0.002
Prior MI 141 437 (31) 31 694 (27.9) 35 441 (31.2) 36 244 (32) 38 058 (32.7) <0.001
Prior PCI 170 440 (37.3) 38 036 (33.5) 41 072 (36.2) 42 630 (37.6) 48 702 (41.8) <0.001
Prior CABG 28 572 (6.26) 6864 (6.04) 6888 (6.07) 7511 (6.6) 7309 (6.3) <0.001
Smoking 88 913 (19.5) 24 723 (21.8) 21 607 (19.05) 21 242 (18.75) 21 341 (18.3) <0.001
Psoriasis 1803 (0.39) 462 (0.41) 536 (0.47) 399 (0.35) 406 (0.35) <0.001
Hypertension 325 031 
(71.16)
80 950 (71.3) 80 412 (71) 80 833 (71.3) 82 836 (71.1) 0.1
Kidney disease 24 822 (5.4) 6454 (5.68) 6276 (5.5) 6233 (5.5) 5859 (5.03) <0.001
Indication
Stable angina 122 111 (26.8) 27 349 (24.2) 28 408 (25.1) 31 675 (28) 34 679 (29.) <0.001
Unstable angina 130 303 (28.6) 30 137 (26.7) 32 681 (28.9) 30 820 (27.2) 36 665 (31.5)
NSTEMI 87 433 (19.2) 23 839 (21.1) 22 237 (19.6) 21 864 (19.3) 19 493 (16.8)
STEMI 111 782 (24.5) 30 565 (27.1) 28 907 (25.5) 27 769 (24.5) 24 541 (21.1)
Others 3880 (0.85) 1030 (0.91) 980 (0.86) 984 (0.86) 886 (0.76)
Data are presented as number (percentage) unless otherwise indicated.
Abbreviations: CABG, coronary artery bypass grafting; MI, myocardial infarction; NSTEMI, non–ST ­segment elevation myocardial 
infarction; PCI, percutaneous coronary intervention; Q1, interval from the minimum to the first quartile; Q2, interval from the first 
quartile to the second quartile; Q3, interval from the second quartile to the third quartile; Q4, interval from the third quartile to 
the maximum; STEMI, ST ­segment elevation myocardial infarction
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of operator ‑volume estimation (FIGURE 1). Howev‑
er, a significant relationship was demonstrat‑
ed for a number of other factors, which coin‑
cided both in the case of the operator volume 
assessed using quartiles and continuous vari‑
ables with an intercept of 100 procedures. Oth‑
er factors related to the mortality rate are pre‑
sented in TABLE 3.
Predictors of mortality in patients with sta‑
ble angina In patients with stable angina, the 
operator volume was not significantly related 
to mortality, regardless of the assessment meth‑
od (quartiles, continuous variables). Factors as‑
sociated with the mortality rate are present‑
ed in TABLE 4.
TABLE 2 Relationships between the number of percutaneous coronary interventions according to quartile and procedure ‑related parameters 
during the 4‑year follow ‑up (2014–2017)
Parameter Total 
(n = 456 732)
Q1: 0–140 
(n = 113 587)
Q2: 141–212 
(n = 113 396)
Q3: 213–305 
(n = 113 295)
Q4: ≥306 
(n = 116 454)
P value
FFR 3997 (0.88) 968 (0.85) 1026 (0.9) 975 (0.86) 1028 (0.88) 0.53
IVUS 3688 (0.81) 1158 (1.02) 977 (0.86) 707 (0.62) 846 (0.73) <0.001
OCT 688 (0.15) 157 (0.14) 204 (0.18) 165 (0.15) 162 (0.14) 0.03
Thrombectomy 15 587 (3.4) 4125 (3.63) 3693 (3.26) 3752 (3.3) 4017 (3.45) <0.001
Rotational ablation 2159 (0.47) 473 (0.42) 505 (0.45) 538 (0.47) 643 (0.55) <0.01
TIMI before PCI 1.91 (1.2) 1.86 (1.21) 1.86 (1.21) 1.92 (1.2) 2 (1.16) <0.001
TIMI after PCI 2.88 (0.52) 2.88 (0.52) 2.87 (0.54) 2.88 (0.52) 2.90 (0.48) <0.001
Contrast volume 183.96 (80.5) 177.71 (79.03) 170.34 (74.6) 161.84 (74.1) 173.4 (77.5) <0.001
Radiation dose 1087.3 (1006.5) 1101.8 (897.8) 1100.6 (1021.9) 1121.3 (1039.7) 1026.4 (1052.7) <0.001
Female PCI operator 12 935 (2.83) 4638 (4.08) 5928 (5.23) 939 (0.83) 1430 (1.23) <0.001
Vascular access (detailed)
Femoral 123 524 (27.1) 38 387 (33.9) 32 243 (28.5) 25 517 (22.6) 27 377 (23.5) <0.001
Radial right 254 486 (55.8) 57 128 (50.4) 60 700 (53.6) 67 331 (59.57) 69 327 (59.6)
Radial left 74 255 (16.3) 16 942 (14.9) 19 510 (17.2) 19 154 (16.9) 18 649 (16)
Other 3533 (0.78) 890 (0.79) 702 (0.62) 1020 (0.9) 921 (0.79)
Chronic total 
occlusion
10 635 (2.3) 1927 (1.7) 2740 (2.4) 2953 (2.6) 3015 (2.6) <0.001
Bifurcation 21 010 (4.6) 4370 (3.8) 4907 (4.3) 5003 (4.4) 6730 (5.8) <0.001
Type of PCI
BMS only 20 218 (4.43) 6230 (5.48) 5563 (4.9) 4483 (3.96) 3942 (3.39) <0.001
BVS and BMS 25 (0.01) 7 (0.01) 2 (0) 5 (0) 11 (0.01)
BVS only 4397 (0.96) 846 (0.74) 974 (0.86) 1273 (1.12) 1304 (1.12)
DES and BMS 2092 (0.46) 421 (0.37) 532 (0.47) 649 (0.57) 490 (0.42)
DES and BVS 433 (0.09) 74 (0.07) 129 (0.11) 127 (0.11) 103 (0.09)
DES, BVS, and BMS 3 (0) 0 (0) 2 (0) 0 (0) 1 (0)
DES only 377 392 (82.6) 90 963 (80.1) 93 779 (82.7) 94 772 (83.6) 97 878 (84)
No stent 51 425 (11.3) 14 638 (12.9) 12 287 (10.8) 11 872 (10.5) 12 628 (10.8)
Unknown type 747 (0.16) 408 (0.36) 128 (0.11) 114 (0.1) 97 (0.08)
Data are presented as number (percentage).
Abbreviations: BMS, bare metal stent; BVS, bioresorbable vascular scaffold; DES, drug ‑eluting stent; FFR, fractional flow reserve; IVUS, intravascular ultrasound; OCT, 
optical coherence tomography; TIMI, Thrombolysis In Myocardial Infarction; others, see TABLE 1
FIGURE 1 Nonlinear relationship with annualized operator volume and risk ‑adjusted mortality 
rate per operator: a local polynomial regression analysis
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operators (Q4) were related to lower mortali‑
ty in the multivariable analysis. Also, when as‑
sessing the procedure volume as a continuous 
variable, we noted borderline significance for 
Predictors of mortality in patients with acute 
coronary syndromes Contrary to the above 
findings, in patients with ACS, procedure vol‑
ume was associated with mortality. High ‑volume 
TABLE 3 Multivariable analysis of the relationship between the operator volume in the overall group of patients 
treated with percutaneous coronary interventions and procedure ‑related mortality rate
Parameter Operator volume per quartile Operator volume per 100 PCIs
OR 95% CI P value OR 95% CI P value
Site volume 0.89 0.83–0.95 <0.001 0.89 0.84–0.95 <0.001
Operator volume
Q2 0.91 0.76–1.08 0.3 – – –
Q3 1.04 0.86–1.25 0.66 – – –
Q4 0.81 0.65–1.01 0.9 – – –
Per 100 PCIs – – – 0.95 0.9–1.006 0.08
Clinical and anthropometric characteristics
Weight, kg 0.92 0.88–0.97 0.006 0.92 0.88–0.97 0.006
Age, y 1.44 1.37–1.51 <0.001 1.44 1.37–1.51 <0.001
Diabetes 1.49 1.34–1.66 <0.001 1.49 1.34–1.66 <0.001
Prior stroke 1.6 1.34–1.91 <0.001 1.61 1.34–92 <0.001
Prior myocardial infarction 1.71 1.5–1.96 <0.001 1.71 1.5–1.96 <0.001
Prior PCI 0.59 0.51–0.69 <0.001 0.59 0.51–0.69 <0.001
Prior CABG 0.5 0.38–0.64 <0.001 0.5 0.38–0.64 <0.001
Smoking 0.79 0.69–0.91 <0.001 0.79 0.69–0.91 <0.001
Psoriasis 1.76 1.02–3.05 0.04 1.76 1.02–3.03 0.04
Hypertension 0.57 0.51–0.63 <0.001 0.57 0.51–0.63 <0.001
Kidney failure 1.59 1.36–1.85 <0.001 1.58 1.36–1.85 <0.001
Year of PCI (2014–2017)
2015 1.17 1.03–1.33 0.01 1.17 1.03–1.33 0.01
2016 1.36 1.19–1.55 <0.001 1.36 1.19–1.55 <0.001
2017 1.32 1.15–1.51 <0.001 1.33 1.16–1.52 <0.001
TIMI grade flow before PCI
I 0.6 0.52–0.68 <0.001 0.6 0.52–0.68 <0.001
II 0.4 0.35–0.47 <0.001 0.4 0.35–0.47 <0.001
III 0.17 0.15–0.2 <0.001 0.17 0.15–0.2 <0.001
Indication
Valvular heart disease 
before PCI
16.6 3.14–87.7 <0.001 16.6 3.51–78.6 <0.001
Cardiac arrest before PCI 11.19 2.05–60.96 0.005 11.19 2.29–54.6 0.002
Chronic total occlusion 0.55 0.4–0.76 <0.001 0.55 0.4–0.76 <0.001
Vascular access
Radial right 0.18 0.16–0.2 <0.001 0.18 0.16–0.2 <0.001
Radial left 0.15 0.12–0.18 <0.001 0.15 0.12–0.19 <0.001
Radiation dose, Gy 1.2 1.15–1.26 <0.001 1.21 1.15–1.26 <0.001
Contrast amount, ml 0.88 0.83–0.93 <0.001 0.88 0.83–0.93 <0.001
Abbreviations: OR, odds ratio; others, see TABLES 1 and 2
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observed both when the operator volume was 
demonstrated continuously and when it was di‑
chotomized at the level of 50 or 75 PCIs annual‑
ly. This analysis comprised all PCIs performed 
over a specified period of time, including elec‑
tive and emergent procedures. 
In a large meta ‑analysis including 23 studies 
and a total of 1 109 103 patients, no strong evi‑
dence for the correlation between the operator 
volume and a reduction in short ‑term mortality 
was shown, although some evidence concerning 
a decrease in major adverse cardiac events for 
high ‑volume operators was revealed. For this 
volume, the mean follow ‑up time was 2.8 years.18 
A study by Badheka et al8 included 457 498 
procedures registered in the National Inpatient 
Sample (NIS) database between 2005 and 2009. 
These procedures were associated with a low‑
er in ‑hospital mortality rate in higher ‑volume 
quartiles (>100 PCIs annually) in comparison 
with the lowest quartile (1–15 PCIs annually). 
The highest ‑volume quartile was connected with 
the greatest reduction. This research was based 
on procedures undertaken no later than in 2010. 
The significance of older investigators in provid‑
ing information about current best practice is 
weakened and should be interpreted with cau‑
tion. In particular, this period witnessed a rap‑
id shift from the use of transfemoral to that of 
transradial vascular access.
The analysis of 323 322 procedures performed 
in 2014 and 2015, registered in a Japanese PCI 
registry, showed no significant differences in 
terms of the in ‑hospital mortality rate or a com‑
posite of periprocedural complications in con‑
nection with the operator volume.14 However, 
although the data covered a similar time and 
the correlation between high ‑volume operators 
and lower mortality rate. The significance of oth‑
er factors assessed by the multivariable analysis 
did not differ when the operator volume was as‑
sessed by quartiles or continuous variables. Oth‑
er factors related to the mortality rate are pre‑
sented in TABLE 5.
DISCUSSION The present study showed that 
there was no significant correlation between 
the operator volume and procedure ‑related mor‑
tality rate in the overall group of patients un‑
dergoing PCIs. Similar results were obtained for 
patients with stable angina. Of note, the mor‑
tality rate in the case of high ‑volume operators 
(Q4) was significantly lower among patients 
undergoing PCI for ACS. Nonetheless, when 
the operator volume was evaluated as a contin‑
uous variable, this correlation did not reach sig‑
nificance. Furthermore, we demonstrated that 
specific procedure ‑related complications were 
negatively correlated with the operator volume. 
We also established a negative association be‑
tween the site (catheterization laboratory) vol‑
ume and procedure ‑related mortality rate, in‑
dependent of whether the PCI procedure was 
primary or elective.
The current literature on the relationship of 
the operator volume with post ‑PCI outcomes 
provides contradictory data. Some studies re‑
ported an increase in the rate of adverse events 
with regard to a lower operator volume following 
risk adjustment, while other studies did not re‑
veal such a link.6-15 Hulme et al17 did not confirm 
a relationship between the 30‑day in ‑hospital 
mortality rate and operator volume. This was 
TABLE 4 Multivariable analysis of the relationship between selected parameters in patients with stable angina 
treated with percutaneous coronary interventions and procedure ‑related mortality rate
Parameter Intercept – quartile Intercept – 100 PCIs
OR 95% CI P value OR 95% CI P value
Weight, kg 0.63 0.41–0.98 0.04 0.63 0.41–0.98 0.04
Left radial vascular 
access
0.06 0.004–0.94 0.04 0.06 0.004–0.92 0.04
Operator volume
Q2 1.65 0.14–18.37 0.68 – – –
Q3 1.09 0.07–15.3 0.95 – – –
Q4 0.8 0.05–12.98 0.9 – – –
Per 100 PCIs – – – 0.97 0.5–1.86 0.92
TIMI grade flow before PCI
I 0.18 0.058–0.59 0.004 0.18 0.059–0.59 0.004
II 0.28 0.08–0.96 0.04 0.28 0.08–0.95 0.04
III 0.13 0.04–0.38 <0.001 0.13 0.04–0.38 <0.001
Abbreviations: see TABLES 1–3
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annually), the CathPCI Registry (59 PCIs an‑
nually; IQR, 21–106), and in the J ‑PCI registry 
in Japan (28 PCIs annually; IQR, 10–56).8,9,14 
Moreover, in the CathPCI registry, 44% of op‑
erators performed fewer than 50 PCIs annual‑
ly, while in our study, more than 72% of oper‑
ators performed more than 75 PCIs annually, 
while 80% of operators or more conducted more 
than 50 PCIs annually. Two studies investigat‑
ing this relationship revealed a post ‑adjustment 
the studies showed similar rates of radial ac‑
cess (61.3% vs 67.5% in our study), cultural dif‑
ferences and the levels of operator volume make 
it difficult to translate the Japanese findings to 
the European context. 
In the present study, the average annual 
number of procedures conducted by a single 
operator was 159. This is considerably higher 
than the number provided in the NIS database 
in the United States (between 33 and 58 PCIs 
TABLE 5 Multivariable analysis of the relationship between selected parameter in patients with acute coronary 
syndromes treated with percutaneous coronary interventions and procedure ‑related mortality rate
Parameter Intercept – quartile Intercept – 100 PCIs
OR 95% CI P value OR 95% CI P value
Site volume 1.24 1.08–1.43 0.001 0.88 0.83–0.95 <0.001
Chronic total occlusion 0.47 0.33–0.66 0.001 0.47 0.33–0.66 0.001
Operator volume
Q2 0.89 0.73–1.07 0.22 – – –
Q3 1.04 0.85–1.27 0.68 – – –
Q4 0.79 0.63–0.99 0.04 – – –
Per 100 PCIs – – – 0.94 0.88–1.0007 0.05
Clinical and anthropometric characteristics
Weight, kg 0.92 0.87–0.97 0.003 0.92 0.87–0.97 0.003
Age, y 1.48 1.41–1.56 <0.001 1.48 1.41–1.56 <0.001
Diabetes 1.47 1.31–1.64 <0.001 1.47 1.31–1.64 <0.001
Prior cerebral stroke 1.72 1.43–2.06 <001 1.72 1.43–2.06 <0.001
Prior myocardial infarction 1.63 1.42–1.86 <0.001 1.63 1.42–1.86 <0.001
Prior PCI 0.52 0.44–0.6 <0.001 0.52 0.44–0.6 <0.001
Prior CABG 0.38 0.28–0.5 <0.001 0.38 0.28–0.5 <0.001
Smoking 0.84 0.73–0.96 0.01 0.84 0.73–0.96 0.01
Psoriasis 1.89 1.09–3.26 0.02 1.88 1.09–3.25 0.02
Hypertension 0.54 0.48–0.6 <0.001 0.54 0.48–0.59 <0.001
Kidney failure 1.58 1.35–1.85 <0.001 1.58 1.35–1.85 <0.001
Year of PCI (2014–2017)
2016 1.24 1.08–1.42 0.001 1.24 1.08–1.42 0.001
2017 1.24 1.08–1.43 0.001 1.25 1.09–1.43 0.001
TIMI grade flow before PCI
I 0.48 0.42–0.55 <0.001 0.48 0.42–0.55 <0.001
II 0.29 0.25–0.34 <0.001 0.29 0.25–0.34 <0.001
III 0.11 0.1–0.14 <0.001 0.11 0.1–0.14 <0.001
Vascular access
Radial right 0.16 0.14–0.18 <0.001 0.16 0.14–0.19 <0.001
Radial left 0.14 0.11–0.17 <0.001 0.14 0.11–0.17 <0.001
Radiation dose, Gy 1.21 1.15–1.27 <0.001 1.21 1.15–1.27 <0.001
Contrast amount, ml 0.89 0.84–0.94 <0.001 0.89 0.84–0.94 <0.001
Abbreviations: see TABLES 1–3
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annual volume. They noted a higher rate of major 
adverse cardiac events (but not deaths) among 
patients treated by operators from the 2 lower 
quintiles. We noted a similar relationship re‑
garding procedure ‑related cardiac arrest, aller‑
gic reactions, bleeding at puncture site, and no‑
‑reflow phenomenon.
Badheka et al8 showed higher risk ‑adjusted 
mortality in patients undergoing PCIs performed 
by low‑ (<16 PCIs/year) in comparison with high‑
‑volume operators (>100 PCIs/year). Nonethe‑
less, the overall in ‑hospital mortality rate was 
not high, reaching only 1.08%, while in our re‑
search, the procedure ‑related mortality rate was 
0.46%. Nevertheless, this number did not in‑
clude all in ‑hospital deaths. Fanaroff et al9 also 
showed a linear increase in in ‑hospital mortality 
following PCI along with a decrease in the oper‑
ator volume. This curve does not have a marked 
inflection point suggesting a minimal annual PCI 
number. Following adjustment for procedure‑
‑related indices (ie, radial access, antithrombot‑
ic agent), differences in mortality rates between 
high‑, intermediate‑, and low ‑volume operators 
decreased, indicating that high ‑volume opera‑
tors apply specific strategies that, in some cases, 
may improve outcomes. This is in line with our 
findings. Additionally, it is possible that some 
low ‑volume operators practice at high ‑volume 
centers.7 Fanaroff et al9 also stated that oper‑
ator volume may sometimes play a greater role 
among lower ‑risk patients, whereas patient fac‑
tors may have excessive impact on the conse‑
quences of the operator volume for the outcomes 
of patients with STEMI. Low ‑volume operators 
perform an inconsistent number of PCIs in the 
emergency setting as well as primary PCIs for 
STEMI, which suggests that they may take on 
a significant role in maintaining PCI access.
Limitations Although previous studies have 
shown discrepancies in cardiovascular outcomes 
according to race and socioeconomic variables, 
these variables were not included in our model 
or other adjustment models used for public re‑
porting. Another important limitation is the lack 
of follow ‑up, including all in ‑hospital complica‑
tions, as well as short‑ and long ‑term follow ‑up 
after discharge. An additional factor that may 
affect the study results is the lack of correction 
for confounders associated with increased car‑
diovascular risk burden in patients with ACS 
undergoing PCI, which can undoubtedly affect 
the bias associated with an apparent increase in 
mortality in this group of patients.
Conclusions The operator volume is not asso‑
ciated with periprocedural mortality in the over‑
all group of patients treated with PCI and in pa‑
tients treated with elective PCI. Nonetheless, 
high operator volume is associated with a lower 
procedure ‑related mortality rate among patients 
decrease in the in ‑hospital mortality rate in 
the case of operators performing over 10 or 11 
primary procedures per year.6,11 In the study 
on CathPCI, the correlation between operator 
volume and in ‑hospital mortality rate was sig‑
nificant among patients with ST ‑segment el‑
evation myocardial infarction (STEMI). Over 
the past 10 years, PCI volumes have declined, 
and numerous operators have noted a corre‑
sponding decrease in the number of conduct‑
ed procedures.19
The study by Fanaroff et al9 reported signif‑
icant differences also in patient ‑related char‑
acteristics for PCIs performed by low‑, inter‑
mediate‑, and high ‑volume operators. Cardio‑
vascular comorbidities were less likely to occur 
in patients who underwent PCI by low ‑volume 
operators than in those subjected to PCI by in‑
termediate‑ or high ‑volume operators. In con‑
trast, PCIs performed by low ‑volume opera‑
tors were more common among patients with 
STEMI than those performed by intermediate‑ 
or  high ‑volume operators, and these were usu‑
ally emergency PCIs. A similar relationship was 
noted in our study.
The main finding of the study by Fanaroff et al9 
was that the majority of operators performed 
an average of 50 PCIs or fewer annually. Com‑
pared with high‑ and intermediate ‑volume op‑
erators (>100 and 50–100 PCIs/year, respective‑
ly), low ‑volume operators (<50 PCIs/year) per‑
formed a higher number of PCIs in emergency 
settings, but a lower number of anatomically 
complex PCIs, treating patients with fewer co‑
morbidities and less often operating multiple le‑
sions during a single visit to the catheterization 
laboratory. In comparison, in our research, low‑
‑volume operators had a tendency to perform 
PCIs more frequently in patients with acute myo‑
cardial infarction, which showed a correlation 
with the higher number of patients with a lower 
TIMI flow grade before and after the procedure. 
Fanaroff et al9 also demonstrated that in the case 
of low ‑volume operators, the hospital PCI vol‑
ume was associated with in ‑hospital mortality 
rates. For low ‑volume hospitals, higher mortali‑
ty rates were noted than for high ‑volume hospi‑
tals. Using the clinical and procedural data from 
the CathPCI registry, they also noted that low‑
‑volume operators tended to use radial access less 
frequently, because the use of greater amounts of 
contrast dye and fluoroscopy took more time. No‑
tably, these operators also commonly practiced 
at lower ‑volume hospitals, treating patients with 
fewer comorbidities but with more acute presen‑
tations and managing less complex lesions than 
in the case of higher ‑volume operators. Similar 
correlations were noted in our study, which was 
conducted during a similar time.
Moscucci et al,20 using data from PCIs per‑
formed in Michigan (2002), proposed a classi‑
fication of operators into quintiles based on an 
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16 Januszek R, Siudak Z, Dziewierz A, et al. Predictors of in -hospital effectiveness 
and complications of rotational atherectomy (from the ORPKI Polish National Reg-
istry 2014–2016). Catheter Cardiovasc Interv. 2018; 92: E278-E287.
17 Hulme W, Sperrin M, Curzen N, et al.; British Cardiovascular Intervention So-
ciety and the National Institute of Cardiovascular Outcomes Research. Operator 
volume is not associated with mortality  following percutaneous coronary  inter-
vention: insights from the British Cardiovascular Intervention Society registry. Eur 
Heart J. 2018; 39: 1623-1634.
18 Strom JB, Wimmer NJ, Wasfy  JH, et al. Association between operator pro-
cedure  volume  and  patient  outcomes  in  percutaneous  coronary  intervention: 
a systematic review and meta -analysis. Circ Cardiovasc Qual Outcomes. 2014; 7: 
560-566.
19 Maroney J, Khan S, Powell W, Klein LW. Current operator volumes of inva-
sive coronary procedures in Medicare patients: implications for future manpower 
needs in the catheterization laboratory. Catheter Cardiovasc Interv. 2013; 81: 34-39.
20 Moscucci M, Share D, Smith D, et al. Relationship between operator volume 
and adverse outcome in contemporary percutaneous coronary intervention prac-
tice: an analysis of a quality -controlled multicenter percutaneous coronary inter-
vention clinical database. J Am Coll Cardiol. 2005; 46: 625-632.
undergoing primary PCI for ACS, as compared 
with low operator volume. High ‑volume cathe‑
terization laboratories are associated with low‑
er procedure ‑related mortality in the overall 
group of patients treated with PCI. In these 
group of patients, high operator volume is also 
related to a  lower rate of procedure ‑related 
complications.
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